Use of diffusion tensor MRI to identify early changes in diabetic nephropathy

L Lu, JR Sedor, V Gulani, JR Schelling… - American journal of …, 2011 - karger.com
Background/Aims: Currently available clinical indicators of kidney disease lack the
sensitivity and/or specificity to identify early-stage diabetic nephropathy (DN). Quantitative …
被引用次数：141 相关文章

Use of Diffusion Tensor MRI to Identify Early Changes in Diabetic Nephropathy

L Lu, JR Sedor, V Gulani, JR Schelling… - American Journal of …, 2011 - karger.com
Abstract Background/Aims: Currently available clinical indicators of kidney disease lack the
sensitivity and/or specificity to identify early-stage diabetic nephropathy (DN). Quantitative …

Use of Diffusion Tensor MRI to Identify Early Changes in Diabetic Nephropathy

L Lu, JR Sedor, V Gulani, JR Schelling… - American Journal of …, 2011 - search.proquest.com
Background/Aims: Currently available clinical indicators of kidney disease lack the
sensitivity and/or specificity to identify early-stage diabetic nephropathy (DN). Quantitative …

Use of Diffusion Tensor MRI to Identify Early Changes in Diabetic Nephropathy

L Lu, JR Sedor, V Gulani, JR Schelling… - American Journal of …, 2011 - cir.nii.ac.jp
抄録< jats: p> Background/Aims: Currently available clinical indicators of kidney disease
lack the sensitivity and/or specificity to identify early-stage diabetic nephropathy (DN) …
[PDF] researchgate.net

[PDF][PDF] Use of Diffusion Tensor MRI to Identify Early Changes in Diabetic Nephropathy

L Lu, JR Sedor, JR Schelling, A O'Brien - Am J Nephrol, 2011 - researchgate.net
Abstract Background/Aims: Currently available clinical indicators of kidney disease lack the
sensitivity and/or specificity to identify early-stage diabetic nephropathy (DN). Quantitative …

Use of diffusion tensor MRI to identify early changes in diabetic nephropathy

L Lu, JR Sedor, V Gulani… - American journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Background/aims Currently available clinical indicators of kidney disease lack the sensitivity
and/or specificity to identify early-stage diabetic nephropathy (DN). Quantitative diffusion …

Use of diffusion tensor MRI to identify early changes in diabetic nephropathy.

L Lu, JR Sedor, V Gulani, JR Schelling… - American Journal of …, 2011 - europepmc.org
Methods 16 diabetic and 5 healthy control subjects were recruited for this institutional review
board-approved/Health Insurance Portability and Accountability Act-compliant study …
[HTML] nih.gov

[HTML][HTML] Use of Diffusion Tensor MRI to Identify Early Changes in Diabetic Nephropathy

L Lu, JR Sedor, V Gulani, JR Schelling… - American Journal of …, 2011 - ncbi.nlm.nih.gov
Methods 16 diabetic and 5 healthy control subjects were recruited for this institutional review
board-approved/Health Insurance Portability and Accountability Act-compliant study …
[PDF] academia.edu

[PDF][PDF] Use of Diffusion Tensor MRI to Identify Early Changes in Diabetic Nephropathy

L Lu, JR Sedor, JR Schelling, A O'Brien - Am J Nephrol, 2011 - academia.edu
Abstract Background/Aims: Currently available clinical indicators of kidney disease lack the
sensitivity and/or specificity to identify early-stage diabetic nephropathy (DN). Quantitative …

Use of diffusion tensor MRI to identify early changes in diabetic nephropathy.

L Lu, JR Sedor, V Gulani, JR Schelling… - American Journal of …, 2011 - europepmc.org
Methods 16 diabetic and 5 healthy control subjects were recruited for this institutional review
board-approved/Health Insurance Portability and Accountability Act-compliant study …